Evidence map›Paper›PMID 26657901›Full record

ArticleGut2017

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.

Pål Møller, Toni Seppälä, Inge Bernstein, Elke Holinski-Feder, Paola Sala, D Gareth Evans, Annika Lindblom, Finlay Macrae, Ignacio Blanco, Rolf Sijmons and 27 more

3 registry-linked trialsOpen access · hybridAbstract readMulticenter Study
In one paragraph

Article in Gut, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 293 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
293citing papers in PubMed, 6 pooled it
22.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02951390 nacompletednot on this map

High Definition White-Light Colonoscopy Versus Chromoendoscopy for Surveillance of Lynch Syndrome. A Prospective, Multicenter and Randomized Study

TypeinterventionalSponsorHospital Clinic of BarcelonaRan2016 to 2017Enrolled280ConditionsLynch SyndromeArmsHigh-definition white-light endoscopy
NCT06708429 recruitingnot on this mapstarted 2023, after this paper: background citation

Impact of Immune-surveillance on the Development of Colorectal Cancer in Patients With Lynch Syndrome

TypeobservationalSponsorSan Raffaele UniversityRan2023 to 2034Enrolled300ConditionsLynch Syndrome, Lynch Syndrome I, Lynch Syndrome II, Lynch Syndrome I (Site-specific Colonic Cancer)ArmsLYNX EYE (Lynch syndrome X-Talk of Enteral mucosa with Immune System)
NCT07360834 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Predicting Cancer Onset in Lynch Syndrome by Liquid Biopsies

TypeinterventionalSponsorUNICANCERRan2026 to 2030Enrolled2,000ConditionsLynch SyndromeArmsINVITRO DIAGNOSTIC TESTS AND COLONOSCOPY
3 · Its place in the literature

Who cites it

293 citing papers in PubMed, 6 syntheses or guidelines pooled it, 538 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.Virchows Archiv : an international journal of pathology · 2021
    Guideline
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

233 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 20 institutions in 10 countries.

Pål MøllerResearch Group Inherited Cancer, Department of Medical Genetics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Toni SeppäläDepartment of Surgery, Central Finland Health Care District, Jyväskylä, Finland.
Inge BernsteinDanish HNPCC Register; Hvidovre University Hospital, Copenhagen, Denmark.
Elke Holinski-FederMedizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Ziemssenstr. 1, Munich, Germany.
Paola SalaUnit of Hereditary Digestive Tract Tumors IRCCS Istituto Nazionale Tumori, Milan, Italy.
D Gareth EvansManchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Annika LindblomDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Finlay MacraeColorectal Medicine and Genetics, The Royal Melbourne Hospital, Melbourne, Australia.
Ignacio BlancoHereditary Cancer Program, Institut Català d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0002-7414-7481
Rolf SijmonsDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Jacqueline JeffriesInstitute of Medical Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, UK.
Hans VasenDepartment of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.
John BurnInstitute of Genetic Medicine Newcastle University, Newcastle upon Tyne, UK.
Sigve NakkenDepartment of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Oslo, Norway.
Eivind HovigDepartment of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Oslo, Norway.
Einar Andreas RødlandDepartment of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Oslo, Norway.
Kukatharmini TharmaratnamDepartment of Mathematics, University of Oslo, Oslo, Norway.
Wouter H de Vos Tot Nederveen CappelDepartment of Gastroenterology and Hepatology, Isala Clinics, Zwolle, The Netherlands.
James HillDepartment of Surgery, Central Manchester University Hospitals NHS Foundation Trust and University of Manchester, Manchester, UK.
Juul WijnenDepartment of Clinical Genetics and Department of Human Genetics Leiden University Medical Centre, Leiden, The Netherlands.
Kate GreenManchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Fiona LallooManchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Lone SundeDanish HNPCC Register; Hvidovre University Hospital, Copenhagen, Denmark.
Miriam MintsDivision of Obstetrics and Gynecology, Department of Women's and Children's health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Lucio BertarioUnit of Hereditary Digestive Tract Tumors IRCCS Istituto Nazionale Tumori, Milan, Italy.
Marta PinedaHereditary Cancer Program, Institut Català d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Matilde NavarroHereditary Cancer Program, Institut Català d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Monika MorakMedizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Ziemssenstr. 1, Munich, Germany.
Laura Renkonen-SinisaloDepartment of Surgery, Helsinki University Hospital, Helsinki, Finland.
Ian M FraylingInstitute of Medical Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, UK.
John-Paul PlazzerColorectal Medicine and Genetics, The Royal Melbourne Hospital, Melbourne, Australia.
Kirsi PylvanainenDepartment of Education and Science, Central Finland Health Care District, Jyväskylä, Finland.
Julian R SampsonInstitute of Medical Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, UK.
Gabriel CapellaHereditary Cancer Program, Institut Català d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Jukka-Pekka MecklinDepartment of Education and Science, Central Finland Health Care District, Jyväskylä, Finland.
Gabriela MösleinDepartment of Surgery, HELIOS St Josefs Hospital Bochum-Linden (Helios), Bochum, Germany.
Mallorca Group (http://mallorca-group.eu)
Institut d'Investigació Biomédica de Bellvitge · ESUniversity of Manchester · GBCardiff University · GBOslo University Hospital · NOCentral Finland Health Care District · FIFondazione IRCCS Istituto Nazionale dei Tumori · ITLeiden University · NLLMU Klinikum · DEThe Royal Melbourne Hospital · AUAalborg University Hospital · DKAarhus University · DKIsala · NLKarolinska Institutet · SEKarolinska University Hospital · SENewcastle University · GBNorwegian Cancer Society · NOSt. Josefs Hospital · DEUniversity Medical Center Groningen · NLUniversity of Eastern Finland · FIUniversity of Helsinki · FI

Funding

Cancer Research UK 15934Medical Research Council G0100496
6 · The paper itself

Abstract

objectiveEstimates of cancer risk and the effects of surveillance in Lynch syndrome have been subject to bias, partly through reliance on retrospective studies. We sought to establish more robust estimates in patients undergoing prospective cancer surveillance.

designWe undertook a multicentre study of patients carrying Lynch syndrome-associated mutations affecting

results1942 mutation carriers without previous cancer had follow-up including colonoscopic surveillance for 13 782 observation years. 314 patients developed cancer, mostly colorectal (n=151), endometrial (n=72) and ovarian (n=19). Cancers were detected from 25 years onwards in

conclusionsThe four Lynch syndrome-associated genes had different penetrance and expression. Colorectal cancer occurred frequently despite colonoscopic surveillance but resulted in few deaths. Using our data, a website has been established at http://LScarisk.org enabling calculation of cumulative cancer risks as an aid to genetic counselling in Lynch syndrome.

Indexed as

Population SurveillanceAdolescentAdultAgedAged, 80 and overAge FactorsChildColonoscopyColorectal Neoplasms, Hereditary NonpolyposisDatabases, FactualDNA-Binding ProteinsEndometrial NeoplasmsFemaleGene ExpressionHeterozygoteHumansDNA-Binding ProteinsG-T mismatch-binding proteinMismatch Repair Endonuclease PMS2MLH1 protein, humanMSH2 protein, humanMutL Protein Homolog 1MutS Homolog 2 ProteinPMS2 protein, humanCANCER GENETICSCANCER PREVENTIONCANCER SYNDROMESCOLONOSCOPYCOLORECTAL CANCER

Identifiers

PMID26657901
PMCPMC5534760
OpenAlexW2191157318

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.